chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I couldn't work and had arthritis in my hand and had flair ups in my joints and skin. In the chest, kidneys and liver. I had inflammation in my organs and throughout my entire body surface and internal. About a week in 7 or 8 days I started getting inflammation or irritation in the chest. It felt like my airways like it was triggering asthma. After 24 hours it went away. In week 2 my skin in my head and my scalp had an inflammation. The follicles were swollen, it was painful and hurt. After two days it went away and became normal. The real problem started in the middle near the end of week two. The hives started I was sitting on the chest and then my chest itched so bad. When I went in the bathroom and looked there were big red whelps on my chest. I took a Benadryl and after 3 hours it went down. Then my back had a big red area of hives on my back. The Hives covered my entire body and it was a huge problem. In addition  I was taking 3 or 4 Benadryl a day. I sought medical care about it. I got into an immunologist/allergists and he did a bunch of labs and bloodwork. He was concerned and not sure if I should take the second shot. He did not give me a recommendation either way. Prescribed antiinflammation and skin cortisone cream.
Patient experienced ringing in the ears, nausea, and hot and clammy skin. 911 was called and patient refused to be taken to the emergency department for treatment.
found apneic & blue; CPR started; paramedics took to ER; no response to ACLS; ?aspiration, SIDS, ?reaction to DTP;
She got her vaccine, she had a sore throat, bad headache and feeling faint.  Her heart was racing real bad, just felt real weak and dizzy.  She went to the infirmary at the facility and they told her to lay down, drink water and to rest.  They did not give her anything for the symptoms.  The symptoms lasted for about a week and then they went away.  The dizziness and headaches still linger, but other than that she lies down for that.    Since she has been out she spoke to her doctor and takes her BP medicine, psyche medicine and Tramadol for the headaches.
Itchy rash with sores, mild headache and lightheadedness(foggy brain) 2-3 days
Received flu shot on 10/25/06. Developed a rash which resembled skin being rub with sand paper.
Case number PHEH2014US018985 is an initial spontaneous report received from a pharmacist on 19 SEP 2014. This report refers to a 66 year old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 145204 (intramuscularly on 16 SEP 2014. It was reported that before administration the FLUVIRIN prefilled syringe was kept at 33.8 degree Fahrenheit for overnight and the next night it reached 32 degree Fahrenheit. It was further reported that the vaccine did not freeze as it was kept in the front of the refrigerator by the door. No adverse event was reported following the administration error (incorrect storage of drug).
I received the Pfizer COVID-19 vaccine through my employer. My first dose was 1/8/21 and my second dose was 1/29/21. I became pregnant through a subsequent IUI cycle on 3/19/2021. We had an amniocentesis at 16 weeks and the results indicated that the baby had a rare chromosomal abnormality - a 1q21.1 microdeletion. I don't think this is related to the vaccine but I wanted to report it. My husband and I are awaiting our own genetic test results to see if we passed it on to the baby or if it was de novo. We ultimately decided to terminate the pregnancy that we wanted so badly due to the high risk for physical and cognitive impairments for our baby. We are devastated.
pain in arm of injection; dizzy; nausea; headache; tingling down arm into fingers; back pain; fever; pressure on chest; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm of injection), DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ) and PARAESTHESIA (tingling down arm into fingers) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ), BACK PAIN (back pain  ), PYREXIA (fever   ) and CHEST DISCOMFORT (pressure on chest). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in arm of injection) and PARAESTHESIA (tingling down arm into fingers). At the time of the report, VACCINATION SITE PAIN (pain in arm of injection), DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ), PARAESTHESIA (tingling down arm into fingers), BACK PAIN (back pain  ), PYREXIA (fever   ) and CHEST DISCOMFORT (pressure on chest) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-216505, MOD-2021-216360 (Patient Link).
flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that her friend experienced flu-like symptoms after receiving the 2nd dose of Shingrix. The reporter did not consent to follow-up. The reporter did not provide any additional details regarding the patients or the event. The case linked with the case US2019196474, reported by same reporter.
I was 14 weeks pregnant for shot 1 and 18 weeks pregnant for shot 2.  My 12 week anatomy scan showed my baby was healthy, all NIPT and amnio came back clean. My baby developed Microcephaly by the next ultrasound scan, 19 weeks. Between 19-23 weeks, her brain slowed down in development even further. I terminated the pregnancy
have Flu-A; Initial information received on 10-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves a patient of unknown age and demographics who experienced have flu-a after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site as Flu vaccination.  On an unknown date, the patient developed a non-serious event have flu-a (influenza) (unknown latency) following the administration of influenza vaccine.  No lab data was reported.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (have Flu-A).  At time of reporting, the outcome was Unknown for the event have flu-a.
Underneath part of my tongue was felt irritated and it was slightly swollen, it was more irritated/ Experienced the some irritation under my tongue; Underneath part of my tongue was felt irritated and it was slightly swollen, it was more irritated; Soreness; Discomfort in my arm; This is a spontaneous report from a contactable consumer (patient). This is first of the two cases. A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN5318, Expiration date: Unknown) via intramuscular route, administered in Upper Arm on 02Feb2021 at 11:00 AM (age of 75-year-old at vaccination) as an 1st dose, single for COVID-19 immunization. The patient also received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: Not reported) via intramuscular route, administered in Upper Arm on 23Feb2021 at 11:00 AM (age of 75-year-old at vaccination) as an 2nd dose, single for COVID-19 immunization. The vaccination facility was reported as other and not military facility. The patient's medical history was reported as none. The patient's concomitant medication(s) included ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS). The patient was not vaccinated with any other vaccine 4 weeks prior to Covid-19 vaccination. On 02Feb2021, (Tuesday), the patient experienced soreness, she was fine just had some discomfort in my arm, and she took some Tylenol, and she was fine. Soreness continued to the next day and was much better. Her husband also had the same reaction and yesterday. On 04Feb2021 (during the night), the patient had underneath part of her tongue was felt irritated and it was slightly swollen, just very slightly but it was more irritated. She drank some water, it did not seem to do anything, she switched with some glycerin and still nothing. So, she took 2 Benadryl, and she went back to sleep and this morning it was slightly better but still little irritated and she had some cereal for breakfast and at this point it was quite a bit better. She had not taken any more medication, she thought if she should take a little more Benadryl just to get it out of her system whatever it is." She noticed it last night about 3 O'clock in the morning, and right now it's almost back to normal totally." She wanted to know if she should take any more Benadryl, or she just let it go since she was better. Three days after second vaccine, she experienced some irritation under my tongue. She took some Benadryl and was fine a few hours later. The patient had not undergone any relevant lab test or any procedures. No investigation assessment was reported. The outcome of the events was recovering.  Follow-up attempts are completed. No further information was expected.
Incorrect site/route - vaccine injected in subcutaneous tissue, rather than the deltoid muscle, of the lower posterior side of upper right arm. I fear this may have an effect on the vaccine efficacy.
Bell's palsy - a feeling of facial paralysis and severe muscle weakness where the neck muscles meet the lower left jaw. This came on quickly as I was sitting down several hours after receiving my first dose, and then subsided over the course of the next 15 minutes or so. I have however a returning sensation of a weaker form of it today, three days after the vaccination event. - a feeling like I can't fully clench my jaw on my lower left side without a notable tingling sensation.
I had 5 injections at the same time. The Yellow Fever was only one of the 5.  The above field did not allow me to report all 5 vaccines. When the injection was given in each arm I felt more pain that previous vaccinations that I have had in the past. Over the next hours, days and weeks, the pain has increased and not gone away. Today is September 10 and I still have a lot of pain.  It is my opinion that I suffered  shoulder injuries 'due to improper injection into my Bursa not my deltoid mussel or to long of needle or both.  I did see my primary health care provider and I was given an oral anti-inflammatory medicine called Prednisone. to treat the problem. The medicine  has helped but the intense pain continues.
Pt recv vax on 3/3/99; on 3/5/99 pt exp red spotty rash on legs; dx=erythema multiforme due to varicella
This case was reported by a healthcare professional and described the occurrence of a 47-year-old male subject not responding to therapy following vaccination with hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix, GlaxoSmithKline) for prophylaxis.  Concurrent medical conditions included elevated blood pressure.  Concurrent vaccination included Salmonella typhi Vi capsular polysaccharide vaccine (Aventis) and tetanus toxoid (Aventis) given on 8 June 2007.  Concurrent medications included Lisinopril and Hydrochlorothiazide (HCTZ).  On 29 June 2007, 15 June 2007 and 8 June 2007 the subject received 3rd dose, 2nd dose and 1st dose of Twinrix (unknown).  On 27 July 2007, 1 month after completion of the Twinrix series, a titer was drawn and was reported as negative.  The subject had not responded to therapy with Twinrix.  At the time of reporting the event was unresolved.
pt recvd vax 13NOV95 @ 1215PM in rt vastus lat, father held pt while nurse giving inj; 15NOV95 dx as localized infection, pt returned to MD on 17NOV95 for further eval of area on rt leg dx is now allerg rxn;Augmentin & DPH given
patient received the 1st dose of the Moderna vaccine and right after had throat tightening up and had to go to the ER; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (patient received the 1st dose of the Moderna vaccine and right after had throat tightening up and had to go to the ER) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939893) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced THROAT TIGHTNESS (patient received the 1st dose of the Moderna vaccine and right after had throat tightening up and had to go to the ER) (seriousness criteria hospitalization and life threatening). At the time of the report, THROAT TIGHTNESS (patient received the 1st dose of the Moderna vaccine and right after had throat tightening up and had to go to the ER) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No treatment medication details was reported.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Guillain-Barre syndrome  Progressive quadriparesis and severe posterior ganglionopathy with bilateral ataxia.
Patient began sweating and feeling lightheaded shortly after vaccination at approximately 1125. Patient then fainted in his chair and was initially non-responsive to the nurse. At this time I called 911. The nurse administered a single epi pen in patient's quad and he woke up. The nurse then took patient's vitals at 1138: BP - 109/73; P-84; SPO2-99%; T-97.4; R-16. Patient stating he was still feeling dizzy and fatigued. The paramedics arrived and took patient to hospital for continued evaluation. I called patient later in the afternoon and he had already been discharged and was at home resting and feeling better.
Vaccine was given high in the left deltoid and pain has continued in left shoulder for 2 weeks. Pain with ROM.
Blood sugar was going up and down after the vaccine; This is a spontaneous report from a non-contactable pharmacist. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via intramuscular route of administration in the right arm on 27Sep2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was unknown. It was unknown whether the patient was pregnant. It was unknown if the patient had any allergies. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Sep2021, the patient experienced blood sugar going up and down after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown if since the vaccination, the patient had been tested for COVID-19. On 27Sep2021, the patient underwent blood glucose test and the result was blood sugar going up and down. It was unknown whether the patient had taken therapeutic measures as a result of the event. The clinical outcome of the event blood sugar was going up and down after the vaccine was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
41 y old M with post vaccine had a mild reaction had a low grade fever 99.5 x 8-10 hours occurred 6 days ago then resolved and a sore arm that resolved
On 3/1/21 a used vial of Pfizer vaccine was reconstituted again with sodium chloride, they were reconstituted in error and patient received diluent only immunization. The immunization administered that day was not effective in providing protection against COVID.   Patient did not have any adverse reaction to the sodium chloride and returned on 3/8/21 to receive the correct dosage of Pfizer vaccine.
Sensation of a squeezing around the chest down to her knees("like a boa constrictor"). No SOB. No nausea/vomiting. Was intermittent. Now lasting 5 seconds at a time, happening several days/week.
Caller reported that his friend informed him that he was not taking the second booster due to loosing his hair after the first booster dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN, Primary Immunization series complete.), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, MANUFACTURER UNKNOWN, Primary Immunization series complete.), for COVID-19 Immunization. The following information was reported: ALOPECIA (non-serious), outcome "recovered", described as "Caller reported that his friend informed him that he was not taking the second booster due to loosing his hair after the first booster dose.".  Additional information: Caller reporting that he & his wife received both doses of the Pfizer Covid 19 Vaccine along with the first booster. Caller reported that his friend informed him that he was not taking the second booster due to losing his hair after the first booster dose. Caller asking if the booster dose has the same ingredient's as the previous booster or if the ingredient's change with each variant. PQC Present was reported as no. Report was related to a study or program was reported as yes. The caller is old and can't hear very well. The caller has a friend who this last time he got the booster dose, not the current one but the previous one. The patient is around 75 and lost some of his hair. Is this booster, the current booster, does it have the same ingredients at the previous booster or do the ingredients change every time there is a new variant. The caller didn't call to give information about this event. The patient's hair has come back and the caller is sure he consulted with (name) and did what they said to do. The patient's hair is back to normal.  The lot number for bnt162b2 was not provided and will be requested during follow up.
The patient was given an adult dose of the Pfizer vaccine 0.3 mL, instead of the 0.2 pediatric dose.
12/01/21 presented to the ED with complaints of chest pressure, elevated BP, slight change in shortness of breath and cough from baseline. Admitted for fluid overload and CHF, but had incidental finding of COVID 19
pt recv 2 doses of vax 4 wk apart;lab testing performed 4wk following 2nd dose of vax indicated that pt had not seroconverted;
Cellulitis of left thigh. Hospital admission IV antibiotics.  3/23/09 Received hospital medical records of 2/4-2/5/2009. FINAL DX: left thigh cellulitis Records reveal patient experienced redness, warmth & edema left leg.  Admitted overnight for observation & tx w/IV antibiotics, steroids & antihistamines.  Seen in ER 2/13/09. FINAL DX: morbilliform rash likely viral exanthem assoc w/URI vs possible drug reaction. Records reveal patient experienced generalized rash, oral sores, low grade fever & URI s/s x 1 day while on oral antibiotics for left thigh cellulitis.  Sibling sick w/cold s/s.  Oral antibiotics d/c.
Rash at location of injection appeared 8 days after first shot.  Rash is red and itchy, but localized to injection site
Upper arm around injection site has been warm since shot. Today, 3/1/2021, I saw i have raised red hives on my left upper arm around the injection site . I have also had a mild headache on and off since the injection.
administration of expired PROQUAD (Lot: T025510; Exp: 23JAN2022) to a 4 year old male patient on 05FEB2022.; No additional AE reported; This spontaneous report was received from Other Health Professional and refers to a 4-year-old male. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 05-FEB-2022, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, route and anatomical location were not provided)  lot #T025510, expiration date: 23-JAN-2022 (Expired product administered) administered for prophylaxis The patient did not experienced additional adverse event.  It was confirmed that measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) had no prior temperature excursion and had be stored per the recommended storage range until administration.
swollen lymph nodes; headache; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.            Concomitant medication use was not reported.   Treatment information was not reported.
Unknown-employee no longer here but KINRIX was given to 12 year old. Only good for 4-6 years. Wrong timing/interval (e.g., interval too short).
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A2) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  No treatment information was provided.
rash over entire body, itching & burning sensation; t101, difficulty breathing, closed throat; oral cortizone given 1st day of sx; injected cortizone given 4th day of sx; lasted 10 days;